Con-Cret: Affected lots are labelled with the incorrect amount of medicinal ingredient
Last updated
Summary
Product
Con-Cret
Issue
Health products - Labelling
What to do
Consult your health care professional if you have any health concerns.
Distribution
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Nova Scotia
Ontario
Prince Edward Island
Quebec
Saskatchewan
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Con-Cret |
Con-Cret |
NPN 80070027 |
Power for Solution |
Glycine, N-(aminoiminomethyl)-N-methyl-, monohydrochloride 750.0 mg |
6CUC23011 |
Issue
Affected lots are labelled with the incorrect amount of medicinal ingredient.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Retailers
Details
Original published date: 2023-07-27
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Vireo Systems, Inc.
305 Williams Ave, Madison
TN USA 37115
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Nova Scotia
Ontario
Prince Edward Island
Quebec
Saskatchewan
Recall class
Type III
Identification number
RA-74020